At the time of approving a vaccine, the Therapeutic Goods Administration (TGA) publishes extensive information about the product for both health professionals and the public. This includes information on the safety considerations made in deciding to approve (or not approve) a particular vaccine in the decision summary and Australian Public Assessment Report.
Weekly safety reports
For COVID-19 vaccines, the TGA will also publish a weekly safety report that includes data on received reports of suspected side effects (also known as adverse events) and other safety information from Australia and overseas.
If we receive information on a possibly significant safety concern from Australian or international sources, we will publish a safety alert and distribute a media release as soon as possible.
These publications will summarise the information received and the investigations being undertaken. Once the investigations are complete, further safety alerts and media releases will be published to explain any findings of the investigation.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.